In men, FSH therapy is used in patients with hypogonadotropic hypogonadism, in which this treatment is well known and established, alone or in combination with human chorionic gonadotropin (hCG) [3,14,15]. Here, BRD2 is linked to hypogonadotropic hypogonadism.